Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
AngioDynamics, Inc. (ANGO) had Return on Investments of -3.31% for the most recently reported fiscal quarter, ending 2025-05-31.
Income Statement Financials | |
$80.16M |
|
$-6.05M |
|
$37.94M |
|
$42.22M |
|
$85.95M |
|
$-5.79M |
|
$-0.32M |
|
$-6.11M |
|
$-6.11M |
|
$-6.05M |
|
$-6.05M |
|
$-6.05M |
|
$-6.05M |
|
$-5.79M |
|
$0.04M |
|
40.85M |
|
40.85M |
|
$-0.15 |
|
$-0.15 |
|
Balance Sheet Financials | |
$168.32M |
|
$32.30M |
|
$111.82M |
|
$280.14M |
|
$76.20M |
|
-- |
|
$20.98M |
|
$97.17M |
|
$182.97M |
|
$113.85M |
|
$182.97M |
|
40.99M |
|
Cash Flow Statement Financials | |
$-10.13M |
|
$-10.18M |
|
$-0.26M |
|
$76.06M |
|
$55.89M |
|
$-20.16M |
|
$9.77M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
52.67% |
|
-7.22% |
|
-7.22% |
|
-- |
|
-7.62% |
|
-7.55% |
|
$-14.59M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.61 |
|
1.87 |
|
48.16 |
|
-3.31% |
|
-5.31% |
|
-2.16% |
|
Return on Investments |
-3.31% |
$4.46 |
|
$-0.36 |
|
$-0.25 |